NSAIDS	Nonsteroidal anti-inflammatory drugs
COX	Cyclooxygenases
PG	Prostaglandin
IC50	Inhibitory concentration
MFA	Mefenamic acid
TA	Tolfenamic acid
MCFA	Meclofenamic acid
FFA	Flufenamic acid
PHGS	Prostaglandin H synthase
AD	Alzheimer’s disease
MRI	Magnetic resonance imaging
CSF	Cerebral spinal fluid
LOAD	Late-onset Alzheimer’s disease
EOAD	Early-onset Alzheimer’s disease
FDA	Federal Drug Administration
NMDA	N-Methyl-D-aspartic acid
APP	Amyloid precursor protein
BACE-1	β-Secretase-1
SP1	Specificity protein 1
MWM	Morris water maze
MAPT	Microtubule-associated protein tau
CDK5	Cyclin-dependent kinase-5
siRNA	small interfering RNA
GSK3β	Glycogen synthase kinase-3 beta
ptau	Phosphotau
hTau	Human tau
NLRP3	NLR family pyrin domain-containing 3
NF-κB	Nuclear factor kappa B
MCI	Mild cognitive impairment
NFT	Neurofibrillary tau tangles
FTD-17	Frontotemporal dementia with parkinsonism-17
PSP	Progressive supranuclear palsy
PD	Parkinson’s disease
EMA	European Medicines Agency
TLRs	Toll-like receptors
AChE	Acetylcholine esterase
ROS	Reactive oxygen species
ICV	Intracerebroventricular
HD	Huntington’s disease
CAG	Cytosine–adenine–guanine
mHtt	Mutant huntingtin
Htt	Huntingtin protein
MSNs	Medium spiny neurons
ASC	Associated speck-like protein
VRAC	Voltage-gated anion channels
NOR	Novel object recognition
VGSC	Voltage-gated sodium channels
MTM	Mithramycin
ASD	Anti-seizure drugs
GAT	GABA transporter 1